Get the Stockscreener App
1.4582
0.69%
0.0132
Allarity Therapeutics Inc stock is traded at $1.4582, with a volume of 247.07K.
It is up +0.69% in the last 24 hours and down -1.02% over the past month.
Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States.
See More
Previous Close:
$1.445
Open:
$1.41
24h Volume:
247.07K
Relative Volume:
0.04
Market Cap:
$21.27M
Revenue:
-
Net Income/Loss:
$-11.90M
P/E Ratio:
-0.00708
EPS:
-206.0125
Net Cash Flow:
$-12.75M
1W Performance:
-9.63%
1M Performance:
-1.02%
6M Performance:
+54.79%
1Y Performance:
-14.91%
1-Day Range:
$1.40
$1.47
1-Week Range:
$1.40
$1.77
52-Week Range:
$0.6138
$2.35
Allarity Therapeutics Inc Stock (ALLR) Company Profile
Name
Allarity Therapeutics Inc
Sector
Industry
Phone
401-426-4664
Address
24 SCHOOL ST., 2ND FLOOR, BOSTON
Compare ALLR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ALLR
Allarity Therapeutics Inc
|
1.455 | 20.99M | 0 | -11.90M | -12.75M | -206.01 |
|
VRTX
Vertex Pharmaceuticals Inc
|
418.97 | 104.76B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
489.73 | 63.06B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
577.38 | 60.32B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
845.47 | 51.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
165.54 | 34.49B | 398.11M | -1.03B | -868.57M | -5.7032 |
Allarity Therapeutics Inc Stock (ALLR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-28-25 | Initiated | Ascendiant Capital Markets | Buy |
Allarity Therapeutics Inc Stock (ALLR) Latest News
How Allarity Therapeutics Inc. stock performs in weak economyJuly 2025 PostEarnings & Risk Managed Investment Entry Signals - newser.com
Is it too late to sell Allarity Therapeutics Inc.2025 Volatility Report & Daily Profit Maximizing Tips - newser.com
Real time social sentiment graph for Allarity Therapeutics Inc.Rate Cut & High Conviction Buy Zone Picks - newser.com
How to build a custom watchlist for Allarity Therapeutics Inc.July 2025 Earnings & Daily Stock Trend Reports - newser.com
Using data filters to optimize entry into Allarity Therapeutics Inc.July 2025 Gainers & Expert Approved Momentum Trade Ideas - newser.com
Real time pattern detection on Allarity Therapeutics Inc. stockAnalyst Downgrade & Risk Managed Investment Signals - newser.com
Intraday pattern recognizer results for Allarity Therapeutics Inc.Portfolio Performance Summary & Fast Moving Stock Trade Plans - newser.com
Allarity Therapeutics registers 1.56M shares for resale - MSN
Published on: 2025-10-12 09:54:11 - newser.com
Published on: 2025-10-12 02:57:16 - newser.com
Is Allarity Therapeutics Inc. meeting your algorithmic filter criteriaJuly 2025 EndofMonth & Long-Term Safe Investment Ideas - newser.com
Is it time to cut losses on Allarity Therapeutics Inc.Quarterly Profit Review & Long Hold Capital Preservation Plans - newser.com
Live market analysis of Allarity Therapeutics Inc.Wall Street Watch & Long-Term Investment Growth Plans - newser.com
Is Allarity Therapeutics Inc. stock a smart buy before Fed meetingAnalyst Downgrade & Expert Curated Trade Ideas - newser.com
Can technical indicators confirm Allarity Therapeutics Inc.’s reversalIndex Update & Free Growth Oriented Trading Recommendations - newser.com
Using data tools to time your Allarity Therapeutics Inc. exitQuarterly Trade Summary & Intraday High Probability Alerts - newser.com
What drives Allarity Therapeutics Inc stock priceMid Cap Growth Trends & Access Free Risk Analysis Before You Invest - earlytimes.in
Is a relief rally coming for Allarity Therapeutics Inc. holdersEarnings Beat & Technical Buy Zone Confirmation - newser.com
What Wall Street predicts for Allarity Therapeutics Inc. stock priceJuly 2025 Closing Moves & Verified Momentum Stock Ideas - newser.com
What MACD and RSI say about Allarity Therapeutics Inc.2025 Dividend Review & Weekly Market Pulse Updates - newser.com
Allarity Therapeutics, Inc. (NASDAQ:ALLR) Sees Large Decrease in Short Interest - Defense World
Allarity Therapeutics Inc Stock (ALLR) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.89%
0.61%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):